Melasma Disease Background

Last updated: 08 August 2025

Content on this page:

Content on this page:

Introduction

Melasma is an acquired hyperpigmentary skin disorder characterized by irregular light to dark brown macules occurring in the sun-exposed areas of the face, neck and arms.

Epidemiology

The prevalence of melasma varies according to ethnicity, sunlight intensity and skin phototype. Melasma most commonly affects Fitzpatrick skin phototypes III-V. The condition is more common in women than in men. This is rare before puberty and common in women during their reproductive years. Melasma occurs most commonly with pregnancy (chloasma) and with the use of contraceptive pills.  

Epidemiological studies reported higher prevalence of melasma in Middle Eastern, East Asian (Japanese, Korean, and Chinese), Indian, Pakistani and Mediterranean-African populations. The prevalence rate in the Southeast Asian population is 40%.  

Pathophysiology

The pathophysiology of melasma involves various factors that lead to enhanced melanin production, such as proopiomelanocortin production, melanocortin-1 receptors (MC-1R) on the melanocyte surface, protein kinase-C activation from diacylglycerol secretion, cGMP pathway triggered by the release of nitric oxide and increased cytokine and subsequent growth factor production.

Risk Factors

Solar and ultraviolet (UV) exposure (eg high-energy visible light, long-wave UVA [UVA-1]) is the most important factor in the development of melasma. Risk factors may include pregnancy, the use of oral contraceptives or hormone replacement therapy, and family history of melasma.  Other factors implicated in the etiopathogenesis of melasma are photosensitizing medications (eg non-steroidal anti-inflammatory drugs [NSAIDs], Acetamoniphen, cardiovascular drugs, antineoplastic agents, antiepileptic agents, antibiotics, prostaglandin analogs), genetic factors (eg Val92Met genotype of the MC1R gene, vitamin D receptor gene polymorphism [TaqI], estrogen receptor gene polymorphisms), mild ovarian or thyroid dysfunction, and certain cosmetics. 

Classification

Clinical Classification of Melasma  

Based on clinical pattern, melasma may be classified as: Centrofacial, which is the most common type with macules and patches on the cheek, forehead, upper lip, nose and chin; malar, which appears on the cheeks and nose; and mandibular lesions, which are seen over the ramus of the mandible where the pigment may also have a bluish appearance.  

Histological Classification of Melasma



Melasma_Disease BackgroundMelasma_Disease Background




Epidermal  

An epidermal melasma appears as light brown with enhancement of pigmentation under Wood’s light. The melanin increases in the basal, suprabasal and stratum corneum layers with highly dendritic and pigmented melanocytes. The epidermal pigment is more amenable to treatment than dermal pigment.  

Dermal  

A dermal melasma appears as ashen or bluish-gray with no enhancement of pigmentation under Wood’s light. Perivascular melanophages on the superficial and deep dermis with less hyperpigmentation are seen in the epidermal layer.  

Mixed  

A mixed type of melasma appears as dark brown with enhancement seen in some areas only. Melanin deposition is found in the epidermis and dermis. This is the most commonly reported (23-80%) type of melasma.  

Indeterminate  

An indeterminate melasma is inapparent under Wood’s light. The melanin deposition is found in the dermis and the pigment is not discernible in dark skin. This is seen in Fitzpatrick’s skin phototype V-VI.